Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Pharmaceuticals    

Global Drug formulations Market Research Report

PRODUCT TITLE PUBLISHED
Equine Encephalomyelitis Equine Encephalomyelitis
Equine Encephalomyelitis and Strangles, Equine Influenza,
Upcoming
Strangles Strangles
Strangles and Equine Encephalomyelitis, Equine...
Upcoming
Equine Influenza Equine Influenza
Equine Influenza and Equine Encephalomyelitis, Strangles,
Upcoming
Equine Rhinopneumonitis Equine Rhinopneumonitis
Equine Rhinopneumonitis and Equine Encephalomyelitis,
Upcoming
Vibriosis Vibriosis
Vibriosis and Pasteurellosis, Furunculosis and
Upcoming
Pasteurellosis Pasteurellosis
Pasteurellosis and Vibriosis, Furunculosis and
Upcoming
Furunculosis Furunculosis
Furunculosis and Vibriosis, Pasteurellosis and
Upcoming
Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists
Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists and Lutienizing Hormone-Releasing Hormone (LHRH) Analogs and
Upcoming
Lutienizing Hormone-Releasing Hormone (LHRH) Analogs Lutienizing Hormone-Releasing Hormone (LHRH) Analogs
Lutienizing Hormone-Releasing Hormone (LHRH) Analogs and Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists and
Upcoming
Anti-Androgens Anti-Androgens
Anti-Androgens and Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists and
Upcoming
Phase III (Immunotherapy) Phase III (Immunotherapy)
Phase III (Immunotherapy) and Phase I (Immunotherapy) and
Upcoming
Phase III (Targeted Therapy) Phase III (Targeted Therapy)
Phase III (Targeted Therapy) and Phase I (Targeted Therapy) and
Upcoming
Phase III (Hormonal Therapy) Phase III (Hormonal Therapy)
Phase III (Hormonal Therapy) and Phase I (Hormonal Therapy) and
Upcoming
North America Live attenuated vaccines North America Live attenuated vaccines
The North American Live attenuated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $805 million in 2013 and expected to be $999 million by 2018 at a CAGR of 4.4%. Live attenuated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
European Live attenuated vaccines Market European Live attenuated vaccines Market
The European Live attenuated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $956 million in 2013 and expected to be $1253 million by 2018 at a CAGR of 5.6%. Live attenuated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
Asian Live attenuated vaccines Market Asian Live attenuated vaccines Market
The Asian Live attenuated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $428 million in 2013 and expected to be $745 million by 2018 at a CAGR of 11.7%. Live attenuated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
North American Inactivated vaccines Market North American Inactivated vaccines Market
The North American Inactivated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $627 million in 2013 and expected to be $818 million by 2018 at a CAGR of 5.5%. Inactivated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
European Inactivated vaccines Market European Inactivated vaccines Market
The European Inactivated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $744 million in 2013 and expected to be $1026 million by 2018 at a CAGR of 6.6%. European Inactivated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
Asian Inactivated vaccines Market Research Report Asian Inactivated vaccines Market Research Report
The Asian Inactivated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $333 million in 2013 and expected to be $610 million by 2018 at a CAGR of 12.9%. Asian Inactivated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
North American Sub-unit vaccines Market North American Sub-unit vaccines Market
The North American Sub-unit Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $29 million in 2013 and expected to be $37 million by 2018 at a CAGR of 4.8%. North American Sub-unit Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
693 reports | Show
Connect With Us
US/CAN : +1-888-502-0539